行情

IBIO

IBIO

IBIO
AMEX

实时行情|Nasdaq Last Sale

2.660
+0.210
+8.57%
盘后: 2.720 +0.06 +2.26% 19:58 08/13 EDT
开盘
2.480
昨收
2.450
最高
2.780
最低
2.450
成交量
2,862.62万
成交额
--
52周最高
7.45
52周最低
0.0500
市值
3.73亿
市盈率(TTM)
-2.2485
分时
5日
1月
3月
1年
5年

EPS

IBIO 新闻

更多
Investors bag profits in COVID-19 vaccine players after run-up
Seeking Alpha - Article · 1天前
Moderna supply deal lifts COVID-19 vaccine players
Seeking Alpha - Article · 1天前
Russia nod on COVID-19 vaccine a propaganda win for Putin - NYT
Seeking Alpha - Article · 2天前
Putin claims Russia has developed the first coronavirus vaccine
Seeking Alpha - Article · 2天前
IBio shares are trading higher after the company provided an update on its Covid-19 vaccine program. Within the update, the company noted anti-SARS-CoV-2 spike titers to IBIO-201 were observed 21 days after immunization.
Benzinga · 3天前
iBio Provides Update on IBIO-201 COVID-19 Vaccine Program
GlobeNewswire · 3天前
IBio rallies on advancement of COVID-19 vaccine program
Seeking Alpha - Article · 3天前
iBio Says 'Early functional testing of mouse antisera from IBIO-201 immunized mice demonstrates the presence of antibodies that interfere with the binding of SARS-CoV-2 spike protein sequences to human ACE2 in ex vivo assays'
NEW YORK, Aug. 10, 2020 (GLOBE NEWSWIRE) -- iBio, Inc. (NYSE:IBIO) ("iBio" or the "Company"), a biotechnology corporation and biologics contract manufacturing organization, today provided an
Benzinga · 3天前

所属板块

制药
-0.45%
制药与医学研究
-0.06%

热门股票

代码
价格
涨跌幅

IBIO 简况

iBio, Inc. is a biotechnology company. The Company is focused on commercializing its technologies and product candidates and providing product development and manufacturing services to clients and collaborators. Its technologies include iBioLaunch technology and iBioModulator. The Company's technologies constitute a transformative platform for development and production of biologics in hydroponically grown green plants. The Company is focused on the commercialization of its plant-based protein expression technologies for vaccines and therapeutic proteins and on developing and commercializing select biopharmaceutical product candidates. The Company's technology is applicable in a range of product candidates, including products against fibrotic diseases, vaccines, enzyme replacements, monoclonal antibodies, and recombinant versions of marketed products that are derived from human blood plasma.
展开

微牛提供Ibio Inc(AMEX-IBIO)的股票价格,实时市场报价,专业分析师评级,深度图表和免费的IBIO股票新闻,以帮助您做出投资决策。

模拟交易:模拟炒股免费实操交易技能。您可用虚拟资金在真实市场环境中零成本、零风险体验交易IBIO股票基本功能。